Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective
LG Ferreira, AD Andricopulo - Drug Discovery Today, 2016 - Elsevier
Highlights•Neglected tropical diseases affect approximately one billion people
worldwide.•Most of the available drugs have limited efficacy and cause serious adverse …
worldwide.•Most of the available drugs have limited efficacy and cause serious adverse …
Neglected tropical protozoan diseases: drug repositioning as a rational option
M Laura Sbaraglini, M Cristina Vanrell… - Current topics in …, 2016 - ingentaconnect.com
Neglected tropical diseases represent a major sanitary problem and a huge economic
burden to endemic countries, and are currently expanding to non-endemic countries owing …
burden to endemic countries, and are currently expanding to non-endemic countries owing …
Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning
M Kaiser, P Mäser, LP Tadoori, JR Ioset, R Brun - PloS one, 2015 - journals.plos.org
Neglected tropical diseases cause significant morbidity and mortality and are a source of
poverty in endemic countries. Only a few drugs are available to treat diseases such as …
poverty in endemic countries. Only a few drugs are available to treat diseases such as …
[HTML][HTML] Drug repurposing and human parasitic protozoan diseases
Parasitic diseases have an enormous health, social and economic impact and are a
particular problem in tropical regions of the world. Diseases caused by protozoa and …
particular problem in tropical regions of the world. Diseases caused by protozoa and …
Drug discovery for neglected tropical diseases at the Sandler Center
SA Robertson, AR Renslo - Future medicinal chemistry, 2011 - Taylor & Francis
The Sandler Center's approach to target-based drug discovery for neglected tropical
diseases is to focus on parasite targets that are homologous to human targets being actively …
diseases is to focus on parasite targets that are homologous to human targets being actively …
Target repurposing for neglected diseases
MP Pollastri, RK Campbell - Future medicinal chemistry, 2011 - Taylor & Francis
Infectious diseases are an enormous burden to global health and, since drug discovery is
costly, those infectious diseases that affect the developing world are often not pursued by …
costly, those infectious diseases that affect the developing world are often not pursued by …
Defining the targets of antiparasitic compounds
TS Skinner-Adams, SDM Sumanadasa, GM Fisher… - Drug discovery today, 2016 - Elsevier
Highlights•New antiparasitic drugs with novel modes of action are needed.•Although new
compounds are being identified, mode of action (s) is often not known.•Here we describe …
compounds are being identified, mode of action (s) is often not known.•Here we describe …
Screening the medicines for malaria venture pathogen box across multiple pathogens reclassifies starting points for open-source drug discovery
Open-access drug discovery provides a substantial resource for diseases primarily affecting
the poor and disadvantaged. The open-access Pathogen Box collection is comprised of …
the poor and disadvantaged. The open-access Pathogen Box collection is comprised of …
Drug discovery and development for neglected parasitic diseases
AR Renslo, JH McKerrow - Nature chemical biology, 2006 - nature.com
Diseases caused by tropical parasites affect hundreds of millions of people worldwide but
have been largely neglected for drug development because they affect poor people in poor …
have been largely neglected for drug development because they affect poor people in poor …
[图书][B] Antiparasitic and antibacterial drug discovery: from molecular targets to drug candidates
PM Selzer - 2009 - books.google.com
Addressing parasitic diseases and those caused by bacteria, this much needed reference
and handbook provides a unique insight into the approach adopted by commercial science …
and handbook provides a unique insight into the approach adopted by commercial science …